Molecular basis of antifungal drug resistance in yeasts

Florent Morio, Rasmus Hare Jensen, Patrice Le Pape, Maiken Cavling Arendrup

64 Citations (Scopus)


Besides inherent differences in in vitro susceptibilities, clinically-relevant yeast species may acquire resistance upon exposure to most antifungal drugs used in the clinic. In recent years, major fundamental research studies have been conducted to improve our understanding of the molecular basis of antifungal resistance. This topic is of major interest as antifungal resistance in yeast is clearly evolving and is correlated with clinical failure. This minireview is an overview of the most recent findings about key molecular mechanisms evolving in human pathogenic yeasts, particularly Candida spp., in the context of antifungal drug resistance. Also included are the methods currently available for in vitro antifungal susceptibility testing and for molecular detection of mutations associated with resistance. Finally, the genetic drivers of antifungal resistance are discussed in light of the spectra of multidrug resistance as observed in Candida glabrata.

Original languageEnglish
JournalInternational Journal of Antimicrobial Agents
Issue number5
Pages (from-to)599-606
Number of pages8
Publication statusPublished - Nov 2017


  • Journal Article


Dive into the research topics of 'Molecular basis of antifungal drug resistance in yeasts'. Together they form a unique fingerprint.

Cite this